Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

34.63
Delayed Data
As of 9:30am ET
 +0.0125 / +0.04%
Today’s Change
18.60
Today|||52-Week Range
34.93
+10.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization0.000.0029.0K--
 
 
 
Operating ExpensesGross Income0.000.00-29.0K--
 
 
General Expenses17.0M19.2M43.2M--
 
 
 
 
Research And Development13.9M14.3M34.3M--
 
 
 
 
Total Operating Expenses17.0M19.2M43.2M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.0M-19.2M-43.2M--
 
 
 
 
Other Expenses-18.0K83.0K-44.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.1M-19.2M-43.3M--
 
 
 
 
Net Income-17.1M-19.2M-43.3M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.2M34.2M28.8M--
 
 
 
 
Shares To Calculate EPS Diluted34.2M34.2M28.8M--
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.56-$1.50--
 
 
 
 
EPS Diluted-$0.50-$0.56-$1.50--